Comment: Insurance Coverage for Over-the-Counter Preventive Services Without a Prescription
Submitted to the U.S. Departments of Treasury, Labor, and Health and Human Services
Population Health
Policy
Comment: Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Submitted to the Food and Drug Administration and Department of Health and Human Services
Print:
On December 18, 2024, LDI Senior Fellow Sean Hennessy, PharmD, PhD submitted a comment in response to a Request for Comments from the U.S Food and Drug Administration and U.S. Department of Health and Human Services. The request sought input regarding methodological challenges related to data on patient experience.
As an expert in pharmacoepidemiology, the study of the health effects of drugs and other medical products in populations, Dr. Hennessy provides 10 suggestions for improving the use of patient experience data in patient focused drug development.
More on Policy at LDI
Briefing: Medicaid Insurance and Sterilization Access – Opportunity for Change
Presented to Staff from the Office of U.S. Representative Pramila Jayapal
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
Briefing: Health Impacts of Tax Incentives for Low-Income Families
Presented to Members of the Pennsylvania General Assembly and Governor Shapiro’s Office
Testimony: Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Delivered to the United States Senate Committee on Finance
Comment: Development of a Universal Symbol for Language Assistance Services in Health Settings
Submitted to the Office of Minority Health, U.S. Department of Health and Human Services